Spots Global Cancer Trial Database for vincristine sulfate

Every month we try and update this database with for vincristine sulfate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma	NCT00005959	Lymphoma	filgrastim rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul...	18 Years -	National Cancer Institute (NCI)
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma	NCT00736450	Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ...	oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana...	19 Years -	University of Nebraska
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma	NCT02567435	Alveolar Rhabdo... Botryoid-Type E... Embryonal Rhabd... Rhabdomyosarcom... Sclerosing Rhab... Spindle Cell Rh...	Cyclophosphamid... Dactinomycin Irinotecan Hydr... Laboratory Biom... Questionnaire A... Radiation Thera... Temsirolimus Vincristine Sul... Vinorelbine	- 40 Years	National Cancer Institute (NCI)
Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma	NCT00055640	Lymphoma	rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal...	18 Years -	Case Comprehensive Cancer Center
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia	NCT02877303	B Acute Lymphob... B Lymphoblastic...	Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul...	14 Years -	M.D. Anderson Cancer Center
Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma	NCT00070083	Lymphoma	oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul...	19 Years -	National Cancer Institute (NCI)
Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma	NCT00101010	Lymphoma	Filgrastim Pegfilgrastim Rituximab Cyclophosphamid... Pegylated lipos... Prednisone Vincristine Sul...	61 Years -	M.D. Anderson Cancer Center
Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma	NCT00002803	Neuroblastoma	cyclophosphamid... doxorubicin hyd... vincristine sul... conventional su...	- 1 Year	National Cancer Institute (NCI)
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer	NCT00003364	Lung Cancer	cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera...	- 74 Years	National Cancer Institute (NCI)
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma	NCT00070447	Lymphoma	rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... yttrium Y 90 ib...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00040690	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera...	16 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease	NCT00004010	Lymphoma	bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera...	- 21 Years	Children's Oncology Group
Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma	NCT00055640	Lymphoma	rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal...	18 Years -	Case Comprehensive Cancer Center
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma	NCT04166409	Low Grade Astro... Low Grade Gliom... Metastatic Low ... Metastatic Low ...	Biospecimen Col... Carboplatin Magnetic Resona... Quality-of-Life... Questionnaire A... Selumetinib Sul... Vincristine Sul...	2 Years - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia	NCT00002785	Leukemia	filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine mesna methotrexate methylprednisol... pegaspargase prednisone therapeutic hyd... vincristine sul... allogeneic bone... low-LET cobalt-... low-LET photon ...	- 1 Year	Children's Oncology Group
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	NCT00049569	L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo...	cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd...	1 Year - 21 Years	National Cancer Institute (NCI)
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma	NCT00072280	Sarcoma	dactinomycin cyclophosphamid... etoposide ifosfamide vincristine sul... Conventional Su... MESNA (mercapto... Filgrastim	- 2 Years	Children's Oncology Group
Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma	NCT01527149	Stage I Mantle ... Stage II Contig... Stage II Non-Co... Stage III Mantl... Stage IV Mantle...	Autologous Hema... Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Laboratory Biom... Methotrexate Ofatumumab Vincristine Sul...	18 Years - 70 Years	Roswell Park Cancer Institute
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma	NCT00002840	Brain and Centr...	lomustine procarbazine hy... vincristine sul... radiation thera...	16 Years - 69 Years	European Organisation for Research and Treatment of Cancer - EORTC
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS	NCT00000987	Sarcoma, Kaposi HIV Infections	Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine	13 Years -	National Institute of Allergy and Infectious Diseases (NIAID)
Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia	NCT02072785	Adult Acute Lym...	Vincristine Sul... Vincristine Sul...	18 Years - 65 Years	Nanjing Luye Sike Pharmaceutical Co., Ltd.
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma	NCT00006184	Multiple Myelom...	Myeloma Immunog... Bortezomib Cyclophosphamid... Cyclosporine Doxorubicin hyd... Etoposide Fludarabine pho... Prednisone Vincristine Sul... Methotrexate GMCSF (granuloc... GCSF (granulocy...	18 Years - 75 Years	National Institutes of Health Clinical Center (CC)
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma	NCT00032019	Lymphoma	filgrastim rituximab cyclophosphamid... doxorubicin hyd... etoposide prednisone vincristine sul...	-	Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	NCT00408005	T Acute Lymphob... T Lymphoblastic...	Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	National Cancer Institute (NCI)
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma	NCT00275106	Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisolone thioguanine vincristine sul... radiation thera...	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma	NCT00025428	Neuroblastoma	carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the...	1 Year - 18 Years	National Cancer Institute (NCI)
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas	NCT00043979	Sarcoma	F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo...	5 Years - 35 Years	National Institutes of Health Clinical Center (CC)
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	NCT00381680	B-cell Childhoo... L1 Childhood Ac... L2 Childhood Ac... Intermediate Ri...	vincristine sul... prednisone doxorubicin hyd... pegaspargase cytarabine methotrexate dexamethasone etoposide cyclophosphamid... leucovorin calc... filgrastim asparaginase mercaptopurine	1 Year - 29 Years	Children's Oncology Group
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002756	Leukemia	filgrastim asparaginase cyclophosphamid... cytarabine daunorubicin hy... etoposide leucovorin calc... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul...	- 1 Year	Children's Oncology Group
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas	NCT03036904	Diffuse Large B... High Grade B-Ce...	Venetoclax Rituximab Etoposide Vincristine Sul... Cyclophosphamid... Prednisone Doxorubicin Hyd...	18 Years - 80 Years	Weill Medical College of Cornell University
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas	NCT03036904	Diffuse Large B... High Grade B-Ce...	Venetoclax Rituximab Etoposide Vincristine Sul... Cyclophosphamid... Prednisone Doxorubicin Hyd...	18 Years - 80 Years	Weill Medical College of Cornell University
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas	NCT03220022	AIDS-Related Ly... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage...	Cyclophosphamid... Doxorubicin Hyd... Etoposide Filgrastim Ibrutinib Laboratory Biom... Pegfilgrastim Pharmacological... Prednisone Rituximab Vincristine Sul...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00003217	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... methotrexate vincristine sul...	- 21 Years	Children's Oncology Group
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia	NCT02101853	Recurrent B Acu...	Allogeneic Hema... Asparaginase Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Leucovorin Calc... Mercaptopurine Methotrexate Mitoxantrone Mitoxantrone Hy... Pegaspargase Pharmacological... Radiation Thera... Therapeutic Hyd... Thioguanine Vincristine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.	NCT00025597	Neuroblastoma	carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su...	- 1 Year	National Cancer Institute (NCI)
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors	NCT00002610	Kidney Cancer	dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera...	- 21 Years	Children's Oncology Group
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia	NCT03488225	Acute Lymphobla... B Acute Lymphob... B Acute Lymphob...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul...	16 Years -	M.D. Anderson Cancer Center
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma	NCT00428142	Lymphoma	rituximab bortezomib cyclophosphamid... prednisone vincristine sul...	18 Years - 120 Years	Canadian Cancer Trials Group
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer	NCT00980460	PRETEXT I Hepat... PRETEXT II Hepa... PRETEXT III Hep... PRETEXT IV Hepa...	Cisplatin Dexrazoxane Doxorubicin Hyd... Fluorouracil Irinotecan Hydr... Laboratory Biom... Liver Transplan... Temsirolimus Therapeutic Con... Vincristine Sul...	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002744	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ...	1 Year - 9 Years	Children's Oncology Group
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor	NCT00047138	Kidney Cancer	dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera...	- 18 Years	National Cancer Institute (NCI)
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma	NCT00020943	Lymphoma	filgrastim rituximab carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide leucovorin calc... methotrexate prednisone vincristine sul... peripheral bloo...	18 Years - 69 Years	Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Children With Progressive Brain Tumors	NCT00002944	Brain Tumors Central Nervous...	carboplatin lomustine procarbazine hy... thioguanine vincristine sul...	- 9 Years	Children's Oncology Group
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease	NCT00107198	Ann Arbor Stage... Ann Arbor Stage... Childhood Nodul...	Conventional Su... Cyclophosphamid... Doxorubicin Hyd... Prednisone Radiation Thera... Vincristine Sul...	1 Month - 21 Years	Children's Oncology Group
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma	NCT00003101	Brain and Centr...	filgrastim busulfan lomustine procarbazine hy... thiotepa vincristine sul... autologous bone... peripheral bloo...	18 Years -	Memorial Sloan Kettering Cancer Center
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00039377	Adult Acute Lym...	imatinib mesyla... methotrexate vincristine sul... leucovorin calc... peripheral bloo... autologous hema... allogeneic hema... total-body irra... tacrolimus filgrastim etoposide cyclophosphamid... cytarabine laboratory biom...	15 Years - 59 Years	National Cancer Institute (NCI)
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma	NCT00410631	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera...	- 21 Years	National Cancer Institute (NCI)
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors	NCT00003203	Brain Tumors Central Nervous... Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... vincristine sul... adjuvant therap... radiation thera...	3 Years - 21 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Lymphoma	NCT00002835	Lymphoma	Bleomycin Sulfa... Filgrastim (G-C... Recombinant Int... Carmustine Cisplatin (CDDP... Cyclophosphamid... Cytarabine (ARA... Etoposide (VP-1... Idarubicin Ifosfamide Leucovorin Calc... Melphalan Methotrexate Methylprednisol... mitoxantrone hy... Vincristine Sul... Peripheral Bloo... Radiation Thera...	15 Years - 59 Years	M.D. Anderson Cancer Center
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery	NCT00276666	Brain and Centr...	cisplatin lomustine vincristine sul... adjuvant therap... radiation thera...	3 Years - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia	NCT03488225	Acute Lymphobla... B Acute Lymphob... B Acute Lymphob...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul...	16 Years -	M.D. Anderson Cancer Center
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma	NCT00077207	Brain Tumor Central Nervous...	carboplatin temozolomide vincristine sul...	- 10 Years	Children's Oncology Group
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma	NCT00028886	Multiple Myelom...	filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo...	18 Years - 65 Years	National Cancer Institute (NCI)
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma	NCT00017225	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera...	- 20 Years	National Cancer Institute (NCI)
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia	NCT00550992	Leukemia	anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ...	- 1 Year	Dutch Childhood Oncology Group
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01256398	Acute Lymphobla... Adult B Acute L...	Alemtuzumab Allogeneic Hema... Autologous Hema... Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Phosp... Filgrastim Fludarabine Pho... In Vitro-Treate... Laboratory Biom... Leucovorin Calc... Melphalan Mercaptopurine Methotrexate Pegfilgrastim Pharmacological... Tacrolimus Vincristine Sul...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy	NCT00006095	Unspecified Chi...	irinotecan hydr... vincristine sul...	1 Year - 21 Years	Children's Oncology Group
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia	NCT05761171	Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Mixed... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Mixe...	Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cytarabine Echocardiograph... Fludarabine Pho... Hydrocortisone ... Lumbar Puncture Methotrexate Multigated Acqu... Prednisolone Prednisone Revumenib Vincristine Sul...	1 Month - 6 Years	Children's Oncology Group
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET	NCT00392327	Anaplastic Medu... Medulloblastoma	Carboplatin Cisplatin Cyclophosphamid... Filgrastim Isotretinoin Laboratory Biom... Quality-of-Life... Radiation Thera... Vincristine Sul...	3 Years - 21 Years	Children's Oncology Group
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma	NCT01700946	Recurrent B-Cel... Recurrent Child...	dexamethasone vincristine sul... rituximab clofarabine cyclophosphamid... etoposide aldesleukin pegaspargase methotrexate mercaptopurine cytarabine mitoxantrone teniposide vinblastine natural killer ... laboratory biom... therapeutic hyd... allogeneic hema... CliniMACS	- 21 Years	St. Jude Children's Research Hospital
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma	NCT00004188	Neuroblastoma	filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera...	- 30 Years	Children's Oncology Group
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma	NCT00058422	Lymphoma	darbepoetin alf... filgrastim rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... indium In 111 i... yttrium Y 90 ib...	60 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	NCT00002908	Leukemia Lymphoma	bryostatin 1 vincristine sul...	18 Years -	Barbara Ann Karmanos Cancer Institute
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease	NCT00002714	Lymphoma	bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera...	16 Years - 60 Years	National Cancer Institute (NCI)
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery	NCT00427570	Colorectal Canc...	BCG vaccine biological ther... fluorouracil semustine vincristine sul...	- 79 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma	NCT00006258	Brain and Centr...	filgrastim cisplatin cyclophosphamid... etoposide methotrexate vincristine sul... adjuvant therap... radiation thera...	10 Years - 65 Years	National Cancer Institute (NCI)
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia	NCT00002704	Leukemia	filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ...	- 20 Years	National Cancer Institute (NCI)
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma	NCT01359592	Lymphoma	rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... R-CHOP regimen laboratory biom... fludeoxyglucose... selective exter... yttrium Y 90 ib...	18 Years -	SWOG Cancer Research Network
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations	NCT02883049	B Acute Lymphob... B Acute Lymphob... Central Nervous... Testicular Leuk...	Clofarabine Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Etoposide Hydrocortisone ... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	NCT00352534	Stage I Kidney ... Stage II Kidney... Stage III Kidne...	3-Dimensional C... Biospecimen Col... Chest Radiograp... Computed Tomogr... Dactinomycin Doxorubicin Hyd... Echocardiograph... Magnetic Resona... Therapeutic Con... Ultrasound Imag... Vincristine Sul...	- 29 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	NCT00002494	Leukemia Lymphoma	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate prednisone therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ...	15 Years -	Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00040690	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera...	16 Years -	National Cancer Institute (NCI)
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia	NCT00002704	Leukemia	filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ...	- 20 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma	NCT00416676	Neuroblastoma	carboplatin cisplatin cyclophosphamid... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera...	1 Year -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma	NCT00004179	Lymphoma	rituximab CHOP regimen cyclophosphamid... doxorubicin hyd... prednisone vincristine sul...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	NCT00408005	T Acute Lymphob... T Lymphoblastic...	Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma	NCT00030719	Neuroblastoma	filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera...	1 Year - 20 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer	NCT00002822	Lung Cancer	carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide mesna vincristine sul... radiation thera...	-	National Cancer Institute (NCI)
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma	NCT00000801	Lymphoma, Non-H... HIV Infections	Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone	16 Years -	National Institute of Allergy and Infectious Diseases (NIAID)
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma	NCT01190930	Acute Lymphobla... Adult B Lymphob... Ann Arbor Stage... Ann Arbor Stage... Childhood B Acu... Childhood B Acu... Childhood B Lym... Down Syndrome Hypodiploid B A... Philadelphia Ch...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Quality-of-Life... Questionnaire A... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: